| Literature DB >> 21550125 |
Cecilia Ahlgren1, Anders Odén, Sara Haghighi, Oluf Andersen, Tomas Bergström, Jan Lycke.
Abstract
High occurrence of measles, rubella and varicella zoster antibodies has been used as a biomarker for MS (the MRZ test). We analyzed measles antibody titres with respect to measles infection/measles vaccination status in 166 patients with MS or clinically isolated syndrome. Fifty blood donors served as controls. Measles vaccination yielded CSF measles antibodies in fewer patients (62%) than measles infection did (87%, p=0.001) and yielded lower measles titres in both serum and CSF (p<0.001). Controls had lower CSF measles titres than patients with measles vaccination alone (p<0.001). Childhood vaccinations probably reduce the sensitivity of the MRZ diagnostic test for MS.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21550125 DOI: 10.1016/j.jneuroim.2011.04.002
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478